FindMyKOL

Sanjay Popat

Enriched profile

Chief Medical Officer, The Royal Marsden NHS Foundation Trust · The Royal Marsden NHS Foundation Trust

ORCID↗NPINone on file
✓ Itemized profile
RegionNot on fileSpecialtyMedicineFocusLung Cancer Treatments and Mutations+4
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH fundingNone on fileWhy? →

Sanjay Popat is Chief Medical Officer, The Royal Marsden NHS Foundation Trust at The Royal Marsden NHS Foundation Trust. OpenAlex indexes 838 publications with 31,310 citations (h-index 64); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.

Data verified 8 Nov 2026

Overview

Updated 8 Nov 2026

Sanjay Popat is Chief Medical Officer, The Royal Marsden NHS Foundation Trust. The public record shows 838 publications with 31,310 citations (h-index 64), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 13 registered clinical trials.

  • Most recent indexed publication: 2026 · JCO precision oncology
  • Top research focus: Lung Cancer Treatments and Mutations
  • 13 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 8 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)8 trialsSmall Cell Lung Carcinoma7 trialsMesothelioma3 trialsLymphoma1 trialColorectal Cancer1 trialOvarian / Gynecologic Cancer1 trialBreast Cancer1 trialGastroesophageal Cancer1 trialHepatobiliary Cancer1 trialRectal Neoplasms1 trialBiliary Tract Neoplasms1 trialGastrointestinal Stromal Tumors1 trialMesothelioma, Malignant1 trialStomach Neoplasms1 trialEsophageal Neoplasms1 trialCarcinoma, Squamous Cell1 trialAdenocarcinoma of Lung1 trialMultiple MyelomaHead & Neck CancerTuberculosisType 2 DiabetesCOPDThyroid DisordersCOVID-19Pancreatic CancerKidney Cancer / RCCSarcomaCushing's SyndromeChronic Kidney DiseaseNeuro-Oncology / GliomaAcromegalyIdiopathic Pulmonary FibrosisBladder / Urothelial CancerProstate CancerLeukemia (AML/ALL/CML/CLL)MelanomaMyasthenia GravisIBS / Functional GISepsis / Serious Bacterial

Research focus

OpenAlex concept fingerprint
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics

Drugs & molecules

across trials, industry payments and publications
AlectinibClinical trials1Industry payments—Publications3PemetrexedClinical trials1Industry payments—Publications1AtezolizumabClinical trials1Industry payments—Publications—BevacizumabClinical trials1Industry payments—Publications—CarboplatinClinical trials1Industry payments—Publications—NeladalkibClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
European Organisation for Research and Treatment of Cancer - EORTCClinical trials4Industry payments—Royal Marsden NHS Foundation TrustClinical trials4Industry payments—ETOP IBCSG Partners FoundationClinical trials3Industry payments—Nuvalent Inc.Clinical trials1Industry payments—University College, LondonClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
838publications

Publications indexed by OpenAlex, matched via ORCID. 39 in PubMed. Counts exclude supporting files.

31,310citations

Citations across these publications.

64h-index

H-index from these publications. i10-index 257.

Clinical & industry

trials, payments and federal funding
13clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

Updated 8 Nov 2026

Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:

All 13 trial records: search, sort and filter.Explore →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 8 Nov 2026

195 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO, ESTRO Congress, IASLC, ISPOR, ISPOR Europe per OpenAlex. The most recent:

All 195 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 8 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 39 publications: search, sort and filter.Explore →

Congress posts on X

Post links from an X account tied to this person through reviewed identity evidence.

  1. View post by @drsanjaypopat on X

    Listed under ELCC 2026

    Collection sources

    Collected .

These links cover selected congress pages. They do not establish attendance or a complete posting history. Post availability may change.

Online presence

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • X / Twitter

    x.com/DrSanjayPopat

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 8 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • BSc

    MBBS, FRCP, PhD

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗

Editorial & leadership roles

journal and society appointments
  • Chair

    British Thoracic Oncology Group Steering Committee

    2013
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esmo.org ↗
  • Chair

    NCRI Lung Cancer Clinical Studies Group Advanced Disease Sub-group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →icr.ac.uk ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.